Skip to content

ent-Evogliptin Tartrate

ent-Evogliptin Tartrate

Product Description
CAT No.
ALN-E047002
CAS No.
NA
Mol. F.
C19H26F3N3O3 : C4H6O6
Mol. Wt.
401.4 : 150.1
Stock
Please Inquire
RFQ
Chemical Name : (S)-4-((S)-3-Amino-4-(2,4,5-trifluorophenyl)butanoyl)-3-(tert-butoxymethyl)piperazin-2-one (2R,3R)-2,3-dihydroxysuccinate
Smiles : O[C@H]([C@H](C(O)=O)O)C(O)=O.O=C1NCCN(C(C[C@@H](N)CC2=CC(F)=C(F)C=C2F)=O)[C@H]1COC(C)(C)C
Inchi : InChI=1S/C19H26F3N3O3.C4H6O6/c1-19(2,3)28-10-16-18(27)24-4-5-25(16)17(26)8-12(23)6-11-7-14(21)15(22)9-13(11)20;5-1(3(7)8)2(6)4(9)10/h7,9,12,16H,4-6,8,10,23H2,1-3H3,(H,24,27);1-2,5-6H,(H,7,8)(H,9,10)/t12-,16-;1-,2-/m11/s1

Beneficial Effects of Evogliptin, a Novel Dipeptidyl Peptidase 4 Inhibitor, on Adiposity with Increased Ppargc1a in White Adipose Tissue in Obese Mice

Yu-Na Chae, Tae-Hyoung Kim, Mi-Kyung Kim, Chang-Yell Shin, Il-Hoon Jung, Yong Sung Sohn, and Moon-Ho SonnPLoS One. 2015; 10(12): e0144064.

Request For Quotation

Related Products